Pantinin‐Derived Peptides against Veterinary Herpesviruses: Activity and Structural Characterization
ChemMedChem · 2025
DOI: 10.1002/cmdc.202500333 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2025. Verfasst von Rosa Giugliano und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", 80138, Naples, Italy. Hauptthemen laut MEDLINE: Antiviral Agents, Antimicrobial Cationic Peptides, Herpesviridae, Herpesvirus 1, Bovine. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Animal viral infections represent a growing public health concern, as animals serve as reservoirs for pathogens, threatening food safety, biodiversity, and human health. In response, novel antiviral strategies are urgently needed. This study investigates the antiviral activity and structural properties of two antimicrobial peptides, pantinin‐1 and pantinin‐2, both derived from the venom of the scorpion Pandinus imperator , against caprine herpesvirus 1 (CpHV‐1) and bovine herpesvirus 1 (BoHV‐1). The results obtained from the plaque reduction assay and the quantitative real‐time polymerase chain reaction (PCR) indicate that synthetic pantinin‐mimetic peptides exhibited potent antiviral effects at concentrations ranging from 6–25 µM, impairing viral infectivity through direct virucidal action and inhibition of the viral entry and fusion with host cell. To characterize their structural behavior, nuclear magnetic resonance spectroscopy is performed in aqueous and membrane‐mimetic environments (trifluoroethanol (TFE)/H 2 O). In aqueous solution, both peptides predominantly adopted random coil conformations, with pantinin‐2 showing greater secondary structure propensity. In TFE/H 2 O, both peptides transitioned to α ‐helical structures, which are often associated with membrane interaction and antiviral activity. These findings demonstrate that pantinin‐1 and pantinin‐2 possess promising antiviral properties, supporting their potential development as therapeutic agents against herpesviruses and other animal viral infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", 80138, Naples, Italy.
- Department of Veterinary Medicine and Animal Production, University of Naples Federico II, 80137, Naples, Italy.
- Department of Environmental, Biological and Pharmaceutical Sciences and technologies, University of Campania, 81100, Caserta, Italy.
- Institute of Biostructures and Bioimaging (IBB), National Research Council (CNR), 80131, Naples, Italy.
- Department of Agricultural Science, University of Naples Federico II, 80055, Portici, Italy.
ORCID-Profile: Carla Zannella, Valentina Iovane, Anna De Filippis
Zitieren
APA
Giugliano, R., Zannella, C., Chianese, A., Acconcia, C., Monti, A., Della Marca, R., Pagnini, U., Montagnaro, S., Doti, N., Isernia, C., Galdiero, M., Fiorito, F., Russo, L., Iovane, V., & De Filippis, A. (2025). Pantinin‐Derived Peptides against Veterinary Herpesviruses: Activity and Structural Characterization. ChemMedChem. https://doi.org/10.1002/cmdc.202500333
Vancouver
Giugliano R, Zannella C, Chianese A, Acconcia C, Monti A, Della Marca R, et al. Pantinin‐Derived Peptides against Veterinary Herpesviruses: Activity and Structural Characterization. ChemMedChem. 2025. doi:10.1002/cmdc.202500333
BibTeX
@article{Giugliano2025,
author = {Giugliano, Rosa and Zannella, Carla and Chianese, Annalisa and Acconcia, Clementina and Monti, Alessandra and Della Marca, Roberta and Pagnini, Ugo and Montagnaro, Serena and Doti, Nunzianna and Isernia, Carla and Galdiero, Massimiliano and Fiorito, Filomena and Russo, Luigi and Iovane, Valentina and De Filippis, Anna},
title = {Pantinin‐Derived Peptides against Veterinary Herpesviruses: Activity and Structural Characterization},
journal = {ChemMedChem},
year = {2025},
doi = {10.1002/cmdc.202500333}
}
EUVIMED